Taiwan's Medical AI Targets National Deployment via FHIR Box; Aims for Global Markets
陳適安:台灣醫療AI拚全國落地FHIR Box串起跨院應用、進軍歐盟 - LINE TODAY
Summary
According to Dr. Shih-An Chen of Taipei Veterans General Hospital, Taiwan's medical AI is moving beyond single-hospital validation toward nationwide clinical application using the Ministry of Health and Welfare's 'FHIR Box'. This strategy aims to accelerate international market entry while complying with global regulations.
Details
Dr. Shih-An Chen highlighted that Taiwan's medical AI development has transitioned from a research phase into practical implementation. The key focus is now on standardizing and securely integrating diverse data—such as EMR, imaging, and lab results—from multiple hospitals and facilities using the Ministry of Health and Welfare’s 'FHIR Box'. This synergy between the 'FHIR Box' and TSHA (Taiwan Smart Healthcare Alliance) aims to establish a pathway for AI application in regional clinical decision support and precision medicine across entire regions. For international expansion, compliance with stringent regulations like the EU's AI Act, GDPR, and MDR is critical. Chen pointed out that Taiwan leverages its unique advantage of integrating semiconductor technology with AI (e.g., cancer detection using nano-bio chips) to pursue global certifications. The background includes monitoring trends from the US FDA and the rapid expansion of the global digital health market. Taiwan aims to elevate AI beyond a mere 'research aid' into an advanced industry that participates directly in scientific discovery and drug development. The initiative requires collaboration among government bodies (Ministry of Science, Ministry of Health, Ministry of Economic Affairs), medical institutions, and academia. By establishing robust data governance and adhering to international standards, Taiwan aims to become not just a base for AI research and validation, but a global hub for exporting smart healthcare products.
Original content copyright by respective publishers